Improving Surgery for Women With Ovarian Cancer Using Special Imaging Technology

Recruiting · Phase 3 · Ovarian Cancer and related conditions · New Jersey, New York, Pennsylvania and Texas

Check if I qualify View on ClinicalTrials.gov

About this trial

This study looks at a new way to use imaging during surgery for women with ovarian cancer. The goal is to see if a special camera system can help reduce problems after surgery, compared to regular methods. The camera uses a glowing dye to check blood flow in real-time, which can help surgeons fix any issues during the operation.

The trial ID is NCT04878094. It is a Phase 3 study, meaning it is looking at how well the treatment works and how safe it is. The trial is not testing a new drug but is using an FDA-regulated device. About 310 participants are expected to join.

Who can join

Women aged 18 and older with ovarian, fallopian tube, or primary peritoneal cancer can join. They should be scheduled for a specific type of surgery. Women who have had allergic reactions to the dye used in the imaging or who need a permanent colostomy cannot participate. The trial team will confirm eligibility for each participant.

Conditions

Ovarian Cancer, Ovarian Carcinoma

Age group

All ages

Sex

Female

The study team makes the final call on eligibility.

What happens in the study

Participants are randomly placed into two groups. One group will have surgery using standard methods, while the other group will have the additional imaging to check blood flow during the procedure. Everyone will receive an injection of a special dye for visualization. The imaging system will be used after the surgery to check the healing area.